Finance

Can-Fite stock jumps 18% on pancreatic cancer trial data

Can-Fite stock jumps 18% on pancreatic cancer trial data

I
Investing.com
April 30, 2026·1 min read
GM
Finance

Can-Fite stock jumps 18% on pancreatic cancer trial data

Original article

Can-Fite stock jumps 18% on pancreatic cancer trial data

Published by Investing.com

Read full article